Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Non-cash Items (2023 - 2025)

Immunome (IMNM) has disclosed Non-cash Items for 3 consecutive years, with $81.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 138.24% year-over-year to $81.5 million, compared with a TTM value of $81.5 million through Dec 2025, up 138.24%, and an annual FY2025 reading of $81.5 million, up 2310.34% over the prior year.
  • Non-cash Items was $81.5 million for Q4 2025 at Immunome, down from $87.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $87.4 million in Q3 2025 and bottomed at $1.6 million in Q2 2023.
  • Average Non-cash Items over 3 years is $32.8 million, with a median of $23.1 million recorded in 2024.
  • The sharpest move saw Non-cash Items soared 2694.75% in 2024, then crashed 91.02% in 2025.
  • Year by year, Non-cash Items stood at $45.4 million in 2023, then fell by 24.58% to $34.2 million in 2024, then surged by 138.24% to $81.5 million in 2025.
  • Business Quant data shows Non-cash Items for IMNM at $81.5 million in Q4 2025, $87.4 million in Q3 2025, and $3.9 million in Q2 2025.